103 episodes

The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.

The MTPConnect Podcast MTPConnect

    • Science
    • 5.0 • 20 Ratings

The MTPConnect Podcast Series connects with the people and the issues behind Australia’s growing medical technologies, biotechnologies and pharmaceuticals sector.

    Partnering in the age of COVID: Real World Tips from Dimerix

    Partnering in the age of COVID: Real World Tips from Dimerix

    In this episode we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. 
    You will hear from Dr Nina Webster, the Managing Director & CEO of Dimerix Limited who shares the highs and lows of forming relationships and doing deals online in the age of COVID-19.
    If you are seeking new strategic partnerships for funding or collaboration this episode is for you. 

    • 18 min
    Are you a medtech or pharma startup? The 2021 Australian Technologies Competition wants you!

    Are you a medtech or pharma startup? The 2021 Australian Technologies Competition wants you!

    This week’s edition of the MTPConnect podcast checks in with the Australian Technology Competition - Australia's national Competition, late-stage accelerator and partnerships program designed to identify and accelerate homegrown scaleups with global potential. Last year, Electrogenics Laboratories won the Australian Technology Company of the Year and also took out the Medtech and Pharma Award, for developing its MOSkin Sensor Technologies, an affordable wireless radiation sensor technology that precisely measures radiation skin doses. Host Shannan Osrin meets their Executive Chairman Kim Lyle who looks back on the impact of the win and the experiences gained, and shares tips on start-up success. Also joining the discussion is Patrick Mooney, Chair of Impact Tech Ventures, the organiser of the Competition. Now in its 11th year, the Competition is supported by the Department of Industry, Science, Energy and Resources, MTPConnect and other Industry Growth Centres, and industry partners. Entries are now open for the Competition in eleven categories, including the Medtech & Pharma Award, and close on 10 May 2021. 

    • 22 min
    Part 2: The Inflazome Story - the research, the deal and scientists that made it happen

    Part 2: The Inflazome Story - the research, the deal and scientists that made it happen

    Tune in for part 2 of our 100th episode special, following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind the milestone research discovery that could lead to a treatment for conditions like Parkinson’s and Alzheimer’s disease, Motor Neurone Disease – even asthma. The innovation was developed out of the UQ, in partnership with Trinity College in Dublin. And the start-up company spawned by the research – Inflazome - was recently acquired by Roche in a deal worth around $600 million, making it one of Australia’s largest ever biotech deals. We also explore the broader work of IMB and the international collaborative approach underpinning its research successes.

    • 25 min
    The Inflazome Story: the research, the deal and scientists that made it happen

    The Inflazome Story: the research, the deal and scientists that made it happen

    Happy 100th episode subscribers! We bring you part 1 of a special double episode following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind the milestone research discovery that could lead to a treatment for conditions like Parkinson’s and Alzheimer’s disease, Motor Neurone Disease – even asthma. The innovation was developed out of the UQ, in partnership with Trinity College in Dublin. And the start-up company spawned by the research – Inflazome -- was recently acquired by Roche in a deal worth around $600 million, making it one of Australia’s largest ever biotech deals. We also explore the broader work of IMB and the international collaborative approach underpinning its research successes.

    • 26 min
    Spotlight: Artrya Marches to its Own Beat

    Spotlight: Artrya Marches to its Own Beat

    In this week’s episode, we chat to WA-based digital health company Artrya’s Co-Founders - CEO John Konstantopoulos and Chairman John Barrington AM - about developing their heart disease detection application, which uses radiology and Artificial Intelligence to more accurately identify patients at risk of Coronary Artery Disease without invasive surgery in a matter of minutes. The ‘software as a service’ solution will also guide cardiologists to deliver more effective treatment. Artrya received funding through MTPConnect’s BioMedTech Horizons program. After starting up two years ago, Artrya have already received TGA registration and are poised to launch pilot programs in WA medical practices. In this episode they reveal more about their mission to save lives and take their solution around the globe. 

    • 33 min
    Adaptive regulation for digital health technologies - a pathway for industry. Listen to Our Seminar!

    Adaptive regulation for digital health technologies - a pathway for industry. Listen to Our Seminar!

    For this episode, we take you to our monthly seminar which is hosted by MTPConnect’s Andrew Bowskill and facilitated by Dr Lisette Pregelj (The University of Queensland). We bring together an expert panel to discuss the opportunities and challenges of embracing Australia’s adaptive regulation process when developing digital health technologies. Hear from Tracey Duffy (Therapeutic Goods Administration), Helen Souris (Cardihab), Dr Rob Grenfell (CSIRO) and Bronwyn Le Grice (ANDHealth) about the value of regulatory approval, the pitfalls and plans digital health innovators need to consider and tips for navigating the TGA processes! This is a must listen to episode for all the Australian digital health entrepreneurs preparing to commercialise their product and take it to markets around the world. You can also download our report ‘Adaptive Regulation for Digital Health’ from the MTPConnect website. 

    • 57 min

Customer Reviews

5.0 out of 5
20 Ratings

20 Ratings

BLTrack ,

Very informative !

They do a great job of letting the speaker speak without interjecting, and looking for key learnings. Good stuff !

spresto0 ,

Hidden Gem

Awesome to have something like this up and running in Australia. Great way to help bridge the gap in knowledge between researchers and industry.

sralophie ,

Inspirational

Why a great podcast, learning about inspirational people in our medical industry.

Top Podcasts In Science

Listeners Also Subscribed To